Patents by Inventor Xueqian Gong

Xueqian Gong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KRAS G12C INHIBITOR DOSING REGIMENS
    Publication number: 20240108618
    Abstract: Disclosed herein are dosing regimens for the administration of a compound of Formula I: or pharmaceutically acceptable salt thereof, or in combination with one or more of a second therapeutic agent, to a patient in need of such treatment.
    Type: Application
    Filed: June 29, 2023
    Publication date: April 4, 2024
    Inventors: David Michael HYMAN, Xueqian GONG, Sheng-Bin PENG, Chong SI, Melinda Dale WILLARD
  • AN AURORA A KINASE INHIBITOR FOR USE IN THE TREATMENT OF NEUROBLASTOMA
    Publication number: 20220000855
    Abstract: The present invention provides an inhibitor of Aurora A kinase, Formula (I) illustrated below, or pharmaceutically acceptable salt thereof, for use in treating neuroblastoma.
    Type: Application
    Filed: November 22, 2019
    Publication date: January 6, 2022
    Inventors: Michele Suzanne DOWLESS, Xueqian GONG, Louis Frank STANCATO
  • Apparatus and method for solid-phase kinetic analysis of templated elongation reactions
    Publication number: 20070184462
    Abstract: Disclosed is an elongation reaction system that includes a membrane compatible with binding an elongation complex and an elongation complex compatible with binding the membrane. The elongation complex includes the biological template (e.g., DNA or RNA), a polymerizing agent (e.g., RNA polymerase, DNA polymerase, or a ribosome), and a primer transcript or polypeptide. Further, disclosed is an apparatus and method for solid-phase kinetic analysis of templated elongation reactions.
    Type: Application
    Filed: September 20, 2006
    Publication date: August 9, 2007
    Inventors: Zachary Burton, Yuri Nedialkov, Xueqian Gong